PeterMouraniMD
Pediatric Pulmonology • Little Rock, ARChronic Lung Disease of Prematurity and Infancy, Pediatric Infectious Disease Pulmonology
Professor, Pediatrics, University of Arkansas for Medical Sciences Senior Vice President and Chief Research Officer, Arkansas Children's Hospital President, Arkansas Children's Research Institute
Dr. Mourani is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Childrens Way 842
Little Rock, AR 72202Phone+1 501-364-6527Fax+1 501-364-4082
Summary
- Dr. Peter Mourani is a pediatric pulmonary and critical care physician in Little Rock, AR at the University of Arkansas for Medical Sciences and Arkansas Children's Hospital, where he serves as the Chief Research Officer and President of the Arkansas Children's Research Institute. He received his medical degree from Loyola University Chicago Stritch School of Medicine and completed his fellowships at the University of Colorado Health Sciences Center. He has been in practice 24 years. He is experienced in neonatal lung development, pulmonary hypertension, severe lower respiratory tract infections, ventilator-associated pneumonia, and clinical and translational research.
Education & Training
University of ColoradoFellowship, Pediatric Critical Care Medicine, 1997 - 2001- University of ColoradoFellowship, Pediatric Pulmonology, 1997 - 2001
Loyola University Medical CenterResidency, Pediatrics, 1994 - 1997
Loyola University Chicago Stritch School of MedicineClass of 1994
Certifications & Licensure
AR State Medical License 2021 - 2026
CO State Medical License 1997 - 2023
IL State Medical License 1994 - 1997- American Board of Pediatrics Pediatric Critical Care Medicine
- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care Start of enrollment: 2011 Nov 01
- Coagulation and Fibrinolysis in Pediatric Insulin Titration Trial (CAF-PINT) Start of enrollment: 2012 Oct 01
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) Start of enrollment: 2020 Mar 05
Publications & Presentations
PubMed
- Children Requiring 3 or More Days of Invasive Ventilation: Secondary Analysis of Post-Discharge Change in Caregiver Employment.Kathryn E Kalata, Kristen R Miller, Yamila L Sierra, Tellen D Bennett, R Scott Watson
Pediatric Critical Care Medicine. 2024-12-19 - PulmonaryIs an Inverse Biomarker of Pneumonia in Critically Ill Children and Adults.Emily C Lydon, Hoang Van Phan, Eran Mick, Natasha Spottiswoode, Carolyn S Calfee
American Journal of Respiratory and Critical Care Medicine. 2024-12-15 - Physical Activity Monitoring in Children in the 1-Year After 3 or More Days of Invasive Ventilation: Feasibility of Using Accelerometers.Aline B Maddux, Kristen R Miller, Yamila L Sierra, Tellen D Bennett, R Scott Watson
Pediatric Critical Care Medicine. 2024-12-05
Press Mentions
One Genomic Test Can Diagnose Nearly Any InfectionNovember 12th, 2024- Frequency and Risk Factors of Acute Kidney Injury During Diabetic Ketoacidosis in Children and Association with Neurocognitive OutcomesDecember 1st, 2020
- ACRI Receives $3.3 Million from NIH to Identify ‘Immunologic Fingerprint’ That Makes Kids More Vulnerable for Severe Respiratory Disease Including COVID-19July 11th, 2024
Grant Support
- Collaborative Network Study of Airway Microbiome and Host Responses in Pediatric Respiratory FailureNIH NICHD2014–2019
- The Microbiome, Virome and Host Responses Preceding Ventilator-Associated PneumoniaNIH NHLBI2014–2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
